Maria Fardis
Patrimonio netto: - $ in data 30/06/2026
Patrimonio netto: - $ in data 30/06/2026
Attualmente, Maria Fardis ricopre la posizione di presidente, amministratore delegato e direttore di Iovance Biotherapeutics, Inc. È anche nel consiglio di Alliance for Regenerative Medicine e Kartos Therapeutics, Inc. In passato è stata Chief Operating Officer di Acerta Pharma LLC, Associate Director-Project & Portfolio Management di Gilead Sciences, Inc., Chief Operating Officer di Acerta Pharma BV e Chief Oncology Operations & Alliances di Pharmacyclics LLC. Il Dr. Fardis ha ricevuto un dottorato dall'Università della California, Berkeley, un MBA dalla Golden Gate University e una laurea presso l'Università dell'Illinois a UrbanaChampaign.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CRISPR THERAPEUTICS AG | Direttore/Membro del Consiglio | 09/06/2022 |
Lassen Therapeutics 1, Inc.
Lassen Therapeutics 1, Inc. BiotechnologyHealth Technology Develops novel and best-in-class biotherapeutics | Amministratore Delegato | 01/04/2023 |
Quanta Therapeutics, Inc.
Quanta Therapeutics, Inc. BiotechnologyHealth Technology Develops biotechnologies | Direttore/Membro del Consiglio | - |
Lassen Therapeutics LLC
Lassen Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company that develops and manufactures therapeutic antibody products | Amministratore Delegato | 04/05/2023 |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Presidente | 19/01/2022 |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Investitore di Private Equity | 22/09/2021 |
Kartos Therapeutics, Inc.
Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company that develops novel and targeted therapeutics | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Amministratore Delegato | 18/06/2021 |
Acerta Pharma LLC
Acerta Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that specializes in drug development | Direttore operativo | 01/03/2016 |
| ░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 16 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Finance |
Golden Gate University
Golden Gate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Health Technology |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
University of Illinois At Urbana–Champaign
University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quanta Therapeutics, Inc.
Quanta Therapeutics, Inc. BiotechnologyHealth Technology Develops biotechnologies | Health Technology |
Kartos Therapeutics, Inc.
Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company that develops novel and targeted therapeutics | Health Technology |
Lassen Therapeutics LLC
Lassen Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company that develops and manufactures therapeutic antibody products | Commercial Services |
Lassen Therapeutics 1, Inc.
Lassen Therapeutics 1, Inc. BiotechnologyHealth Technology Develops novel and best-in-class biotherapeutics | Health Technology |
Acerta Pharma LLC
Acerta Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that specializes in drug development | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale